HK Stock Market Move | INNOGEN-B (02591) plummeted over 24% as it marked one year since its listing, with a total of 384 million shares becoming available for trading.

INNOGEN-B (02591) has plummeted over 24%, falling by 24.51% to HKD 4.99, with a trading volume of HKD 77.3681 million as of the time of writing. In terms of news, Yinnuo Pharmaceutical will be listed on the Hong Kong Stock Exchange on August 15, 2025, marking one year since its listing, after which the 12-month lock-up commitment from the controlling and major shareholders will expire. Data shows that the number of unlocked shares is 384 million, accounting for approximately 91.3% of the circulating shares. According to the Hong Kong Stock Exchange, on August 13, Yinnuo Pharmaceutical experienced a change in positions, with a total market value of stored positions amounting to HKD 189 million, accounting for 6.32%. The company's shareholders deposited 26.5564 million shares into HAITONG INT'L Securities, increasing their shareholding ratio by 6.32%. The company's financial performance for the fiscal year 2025 shows that it generated revenue of approximately RMB 131.5 million, primarily from the sales of Eseragone in China. The net loss was RMB 341 million, a year-on-year increase of 95.4%.